It will shoot up is my guess. Not all practices are high turnover compared to ONT but at this price level, it's a great buy.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025